Eli Lilly stock price ticks up as India export-hub push and pipeline news grab attention
Eli Lilly shares climbed 0.9% to $1,049.45 Tuesday after the company said it aims to make India a global supply-chain hub. Lilly plans to export drugs made in India and invest $1 billion in contract manufacturing. The company also reported a late-stage trial win for its lung cancer drug Retevmo. Investors await more details at a CFO appearance on March 2.